US2019241528A1PendingUtilityA1
Sodium channel blockers
Est. expiryFeb 19, 2022(expired)· nominal 20-yr term from priority
Inventors:Michael R. Johnson
A61P 43/00A61P 37/00A61P 9/12A61P 7/00A61P 37/02A61P 7/10A61P 27/16A61P 29/00A61P 27/02A61P 11/00A61P 11/08A61P 15/02A61P 17/16A61P 11/06A61P 11/12A61P 15/08A61P 1/10A61P 1/04A61P 13/02A61P 1/02A61P 11/02A61P 13/00A61P 17/00A61P 1/00A61P 11/10A61K 31/4965A61K 45/06C07H 15/26C07D 241/26A61K 31/706C07D 405/12C07D 241/32A61K 31/497C07D 241/30C07D 241/28
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A method of preparing a compound of Formula (I):
or a salt thereof, the method comprising a step of reacting a compound of the formula:
or a salt thereof, with a compound of the formula: HNR 3 R 4 , or a salt thereof, wherein:
X is hydrogen, halogen, trifluoromethyl, lower alkyl, unsubstituted or substituted phenyl, lower alkyl-thio, phenyl-lower alkyl-thio, lower alkyl-sulfonyl, or phenyl-lower alkyl-sulfonyl;
Y is hydrogen, hydroxyl, mercapto, lower alkoxy, lower alkyl-thio, halogen, lower alkyl, unsubstituted or substituted mononuclear aryl, or —N(R 2 ) 2 ;
R 1 is hydrogen or lower alkyl;
each R 2 is independently —R 7 , —(CH 2 ) m —OR 8 , —(CH 2 ) m —NR 7 R 10 , —(CH 2 ) n (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —(CH 2 CH 2 O) m —R 8 , —(CH 2 CH 2 O) m —CH 2 CH 2 NR 7 R 10 , —(CH 2 ) n —C(═O)NR 7 R 10 , —(CH 2 ) n —(Z) g -R 7 , —(CH 2 ) m NR 10 -CH 2 (CHOR 8 )(CHOR 8 ) n CH 2 OR 8 , —(CH 2 ) n CO 2 R 7 , or
R 3 and R 4 are each independently hydrogen, a group represented by Formula (A), lower alkyl, hydroxyl lower alkyl, phenyl, phenyl-lower alkyl, (halophenyl)-lower alkyl, lower-(alkylphenylalkyl), lower (alkoxyphenyl)-lower alkyl, naphthyl-lower alkyl, or pyridyl-lower alkyl, with the proviso that at least one of R 3 and R 4 is a group represented by Formula (A):
and wherein:
each R L is independently —R 7 , —(CH 2 ) n —OR 8 , —O—(CH 2 ) m —OR 8 , —(CH 2 ) n —NR 7 R 10 , —O—(CH 2 ) m —NR 7 R 10 , —(CH 2 ) n (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —O—(CH 2 ) m (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —(CH 2 CH 2 O) m —R 8 , —O—(CH 2 CH 2 O) m —R 8 , —(CH 2 CH 2 O) m —CH 2 CH 2 NR 7 R 10 , —O—(CH 2 CH 2 O) m —CH 2 CH 2 NR 7 R 10 , —(CH 2 ) n —C(═O)NR 7 R 10 , —O—(CH 2 ) m —C(═O)NR 7 R 10 , —(CH 2 ) n —(Z) g —R 7 , —O—(CH 2 ) m —(Z) g —R 7 , —(CH 2 ) n —NR 10 -CH 2 (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —O—(CH 2 ) m —NR 10 -CH 2 (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —(CH 2 ) n —CO 2 R 7 , —O—(CH 2 ) m —CO 2 R 7 , —OSO 3 H, —O-glucuronide, —O-glucose,
each o is independently an integer from 0 to 10;
each p is an integer from 0 to 10;
with the proviso that the sum of o and p in each contiguous chain is from 1 to 10;
each x is independently O, NR 10 , C(═O), CHOH, C(═N—R 10 ), CHNR 7 R 10 , or a single bond;
each R 5 is independently —(CH 2 ) m —OR 8 , —O—(CH 2 ) m —OR 8 , —(CH 2 ) n —NR 7 R 10 , —O—(CH 2 ) m —NR 7 R 10 , —(CH 2 ) n (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —O—(CH 2 ) m (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —(CH 2 CH 2 O) m —R 8 , —O—(CH 2 CH 2 O) m —R 8 , —(CH 2 CH 2 O) m —CH 2 CH 2 NR 7 R 10 , —O—(CH 2 CH 2 O) m —CH 2 CH 2 NR 7 R 10 , —(CH 2 ) n —C(═O)NR 7 R 10 , —O—(CH 2 ) m —C(═O)NR 7 R 10 , —(CH 2 ) n —(Z) g -R 7 , —O—(CH 2 ) m —(Z) g -R 7 , —(CH 2 ) n —NR 10 -CH 2 (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —O—(CH 2 ) m —NR 10 -CH 2 (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —(CH 2 ) n —CO 2 R 7 , —O—(CH 2 ) m —CO 2 R 7 , —OSO 3 H, —O-glucuronide, —O-glucose,
each R 6 is independently —R 7 , —OR 11 , —N(R 7 ) 2 , —(CH 2 ) m —OR 8 , —O—(CH 2 ) m —OR 8 , —(CH 2 ) n —NR 7 R 10 , —O—(CH 2 ) m —NR 7 R 10 , —(CH 2 ) n (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —O—(CH 2 ) m (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —(CH 2 CH 2 O) m —R 8 , —O—(CH 2 CH 2 O) m -R 8 , —(CH 2 CH 2 O) m —CH 2 CH 2 NR 7 R 10 , —O—(CH 2 CH 20 ) m —CH 2 CH 2 NR 7 R 10 , —(CH 2 ) n —C(═O)NR 7 R 10 , —O—(CH 2 ) m —C(═O)NR 7 R 10 , —(CH 2 ) n —(Z) g -R 7 , —O—(CH 2 ) m —(Z) g -R 7 , —(CH 2 ) n —NR 10 -CH 2 (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —O—(CH 2 ) m —NR 10 -CH 2 (CHOR 8 )(CHOR 8 ) n —CH 2 OR 8 , —(CH 2 ) n —CO 2 R 7 , —O—(CH 2 ) m —CO 2 R 7 , —OSO 3 H, —O-glucuronide, —O-glucose,
wherein when two R 6 are —OR 11 and are located adjacent to ech other on a phenyl ring, the alkyl moieties of the two R 6 may be bonded together to form a methylenedioxy group;
each R 7 is independently hydrogen or lower alkyl;
each R 8 is independently hydrogen, lower alkyl, —C(═O)-R 11 , glucuronide, 2-tetrahydropyranyl, or
each R 9 is independently —CO 2 R 7 , —CON(R 7 ) 2 , —SO 2 CH 3 , or C(═O)R 7 ;
each R 10 is independently —H, —SO 2 CH 3 , —CO 2 R 7 , —C(═O)NR 7 R 9 , —C(═O)R 7 , or CH 2 —(CHOH) n CH 2 OH;
each Z is independently CHOH, C(═O), CHNR 7 R 10 , C═NR 10 , or NR 10 ;
each R 11 is independently lower alkyl;
each g is independently an integer from 1 to 6;
each m is independently an integer from 1 to 7;
each n is independently an integer from 0 to 7; and
each Q is independently C—R 5 or C—R 6 , wherein one Q is C—R 5 .
3 . The method of claim 2 , wherein the compound of the formula:
is of the formula:
or a salt thereof.
4 . The method of claim 3 , wherein the compound of the formula:
is in the form of a hydroxide salt.
5 . The method of claim 2 , wherein the reaction is carried out in the presence of a base.
6 . The method of claim 5 , wherein the base is diisopropylethylamine or triethylamine.
7 . The method of claim 2 , wherein the reaction is carried out in a solvent.
8 . The method of claim 7 , wherein the solvent is THF or ethanol.
9 . The method of claim 2 , wherein the reaction is carried out at elevated temperature.
10 . The method of claim 8 , where the reaction is carried out at about 66° C.
11 . The method of claim 2 further comprising a step of purifying the compound of Formula (I), or a salt thereof, via chromatography or recrystallization.
12 . The method of claim 2 , wherein each instance of R 1 , R 2 , and R 3 is hydrogen.
13 . The method of claim 2 , wherein X is chlorine.
14 . The method of claim 2 , wherein Y is —NH 2 .
15 . The method of claim 2 , wherein R 4 is of the formula:
16 . The method of claim 2 , wherein R 4 is of the formula:
17 . The method of claim 2 , wherein R 4 is of the formula:
18 . The method of claim 2 , wherein:
each instance of R 1 , R 2 , and R 3 is hydrogen; R 4 is of the formula:
and x is a single bond.
19 . The method of claim 18 , wherein X is chlorine.
20 . The method of claim 18 , wherein Y is NH 2 .
21 . The method of claim 18 , wherein R 5 is —O—(CH 2 ) m (Z) g -R 7 .
22 . The method of claim 21 , wherein g is 1; and Z is NR 10 .
23 . The method of claim 21 , wherein R 10 is CH 2 —(CHOH) n CH 2 OH.Join the waitlist — get patent alerts
Track US2019241528A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.